1. Institute of Cardiovascular Research, Key Laboratory for Atherosclerology of Hunan Province, Medical Research Center, Hengyang, China
2. Department of Spine Surgery, The Second Affiliated Hospital, University of South China, Hengyang, China
3. Department of Biochemistry and Molecular Biology, School of Pharmacy and Life Science University of South China, Hengyang, China
4. Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study, University of South, Hengyang, China
5. Department of Biochemistry & Molecular Biology and Department of Physiology & Pharmacology, Cumming School of Medicine, Libin Cardiovascular Institute of Alberta, University of Calgary, Health Sciences Center, Calgary, Alberta, Canada
6. Key Laboratory of Molecular Targets & Clinical Pharmacology, School of Pharmaceutical Sciences, Guangzhou Medical University, Guangzhou, China
7. Department of Pediatrics and Group on the Molecular and Cell Biology of Lipids, University of Alberta, Alberta, Canada